Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas

BACKGROUND: Tumor hypoxia and glycolysis have been recognized as determinant factors characterizing tumor aggressiveness in malignant gliomas. To clarify in vivo hypoxia and glucose metabolism in relation to isocitrate dehydrogenase (IDH) mutation and chromosome 1p and 19q (1p/19q) codeletion status...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kenta, Kawai, Nobuyuki, Ogawa, Tomoya, Miyake, Keisuke, Shinomiya, Aya, Yamamoto, Yuka, Nishiyama, Yoshihiro, Tamiya, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295439/
https://www.ncbi.nlm.nih.gov/pubmed/34291337
http://dx.doi.org/10.1186/s13550-021-00806-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295439/
https://www.ncbi.nlm.nih.gov/pubmed/34291337
http://dx.doi.org/10.1186/s13550-021-00806-6

Ejemplares similares